Left Menu
Development News Edition

ICMR mulling revision of recommendation to use HCQ for COVID-19 treatment

PTI | New Delhi | Updated: 21-05-2020 00:27 IST | Created: 20-05-2020 23:32 IST
ICMR mulling revision of recommendation to use HCQ for COVID-19 treatment
Representative image Image Credit: ANI

The apex health research body ICMR is mulling a revision of its recommendation to use hydroxychloroquine (HCQ) for treatment of COVID-19 patients after doubts were raised over the effectiveness of the drug. Asked if the government is planning to drop HCQ from the COVID-19 treatment plan and also as preventive medication, Head of Epidemiology and Communicable Diseases at ICMR, Dr Raman R Gangakhedkar on Wednesday said, "A decision in this regard will be taken following a review of all the evidences we are collecting." Meanwhile, the Indian Council of Medical Research (ICMR) is conducting an observational study in which five hospitals have been enrolled to assess the efficacy of the anti-malarial drug hydroxychloroquine as a preventive medication against COVID-19 among healthcare personnel.

According to an ICMR official, there is limited evidence on the efficacy of hydroxychloroquine to deal with COVID-19 cases and therefore, there is not enough proof to recommend it for use by the general public as of now. The ICMR has recommended the use of the drug as a preventive medication to healthcare workers and household contacts looking after a positive case.

Besides, the Union Health Ministry has recommended the use of hydroxychloroquine in combination with azithromycin for patients suffering from severe COVID-19 and requiring ICU management. Hydroxychloroquine is one among the four treatment protocols that are being evaluated during the randomized controlled clinical trials under the WHO's Solidarity trial to find an effective treatment for COVID-19 across select hospitals.

The other three treatment protocols are remdesivir, a combination of lopinavir and ritonavir, and lopinavir and ritonavir with interferon beta-1a. Hydroxychloroquine is an old and inexpensive drug used to treat malaria. India is the largest producer of the drug globally.

Hydroxychloroquine recently failed in two separate randomized controlled trials conducted in China and France, the findings of which were published in the BMJ journal on May 15.


TRENDING

OPINION / BLOG / INTERVIEW

‘Discounted Deaths’ and COVID 19: Anthropology of Death and Emotions

Death is a social event rather than the mere cessation of biological functions. As seen by anthropologists, death is not just physical but intensely social, cultural, and political....

Indigenous knowledge of communities a must for maximizing impact of community work

Generally, it has been observed that the majority of the academicians in higher education institutions neglect the wisdom of community people and throw their weight around thinking that they know everything and the community knows nothing. ...

In rebuking FBR, Pakistan’s courts take a stand for public health

The system, if implemented effectively, will allow Pakistans revenue service to combat the illicit trade in tobacco products and potentially add hundreds of millions of dollars to the states budget each year. ...

Dissecting how COVID-19 is catalyzing the trajectory of New World Order

The ensuing pandemic of COVID-19 has hit the globalization in two ways firstly, shrinking the importance of globalization as an economic force by curtailing mobility through worldwide lockdowns, and secondly, rejuvenating the idea of indig...

Videos

Latest News

US couple waits 2 1/2 months in lockdown to visit Pompeii

An American couple waited a lifetime plus 2 months to visit the ancient ruins of Pompeii together. Colleen and Marvin Hewson, retirees from the Detroit, Michigan area, were first in line when the archaeological site reopened to the public ...

Staffer, 10 inmates of Rohini jail recover from COVID-19

A staff member and 10 inmates of the Rohini jail here, who had tested positive for COVID-19, have recovered from the infection, officials said on Tuesday. A head warden of the Central Jail 10 in Rohini had tested positive for coronavirus on...

NCDEX launches Agridex; trades 418 lots, Rs 21 cr volume on first day

The National Commodity and Derivatives Exchange NCDEX on Tuesday launched Agri Futures Index, which traded a total of 418 lots and Rs 21 crore volume on the first day. Agri Futures Index Agridex traded 102 lots with around Rs 5 crore volume...

UK's John Lewis plans 'phased' re-opening of department stores

British retailer John Lewis Partnership said on Tuesday it will re-open its department stores on a phased basis after the government said non-essential retail could re-open from June 15. John Lewis, which trades from 50 stores across the UK...

Give Feedback